Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2014
Revenue	-	-	-	-	0.14
Revenue Growth (YoY)	-	-	-	-	2.13%
Gross Profit	-	-	-	-	0.14
Selling, General & Admin	16.65	7.68	7.18	4.63	-
Research & Development	41.36	36.97	25.65	10.98	-
Operating Expenses	58.02	44.65	32.83	15.61	-
Operating Income	-58.02	-44.65	-32.83	-15.61	-
Interest Expense	-0.11	-0.15	-0.14	-0.45	-
Interest & Investment Income	4.26	0.58	0.15	-	-
Other Non Operating Income (Expenses)	-4.12	1.4	0.65	8.1	-
EBT Excluding Unusual Items	-57.98	-42.82	-32.18	-7.96	-
Other Unusual Items	-	-	-	-0.97	-
Pretax Income	-57.98	-42.82	-32.18	-8.93	-
Earnings From Continuing Operations	-57.98	-42.82	-32.18	-8.93	-
Net Income	-57.98	-42.82	-32.18	-8.93	0.01
Net Income to Common	-57.98	-42.82	-32.18	-8.93	-
Shares Outstanding (Basic)	8	1	3	-	-
Shares Outstanding (Diluted)	8	1	3	-	-
Shares Change (YoY)	569.30%	-49.78%	-	-	-
EPS (Basic)	-6.83	-33.76	-12.74	-	-
EPS (Diluted)	-6.83	-33.76	-12.74	-	-
Free Cash Flow	-59.24	-40.96	-29.73	-14.58	-
Free Cash Flow Per Share	-6.98	-32.29	-11.77	-	-
Gross Margin	-	-	-	-	100.00%
EBITDA	-56.37	-43.17	-31.82	-15.25	-
D&A For EBITDA	1.65	1.48	1.01	0.36	-
EBIT	-58.02	-44.65	-32.83	-15.61	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q